These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11499428)

  • 1. When should drug treatment be initiated in schizophrenia?
    Malla AK
    J Psychiatry Neurosci; 1999 Sep; 24(4):363. PubMed ID: 11499428
    [No Abstract]   [Full Text] [Related]  

  • 2. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
    Gómez-Perretta C
    Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
    [No Abstract]   [Full Text] [Related]  

  • 3. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
    Strous RD; Lerner V
    Am J Psychiatry; 2005 Mar; 162(3):631-2; author reply 632-3. PubMed ID: 15741496
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors that influence treatment success in schizophrenia.
    Buckley PF
    J Clin Psychiatry; 2008; 69 Suppl 3():4-10. PubMed ID: 18533756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of schizophrenia].
    Houy-Durand E; Thibaut F
    Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Standard: therapeutic antipsychotic neuroleptics in acute approach: a collection of data].
    Bottaï T
    Encephale; 2002; 28 Spec No 2 Pt 2():S27-8. PubMed ID: 12587353
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of long-acting risperidone.
    Parker G
    Psychiatr Serv; 2005 Jan; 56(1):105-6; author reply 106-7. PubMed ID: 15637203
    [No Abstract]   [Full Text] [Related]  

  • 9. The influences of cultural and racial factors upon therapeutic response of the schizophrenic patients.
    Masłowski J
    Psychiatr Pol; 1988; 22(4):273-8. PubMed ID: 2907808
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia].
    Fujii Y
    Seishin Shinkeigaku Zasshi; 2001; 103(12):1030-5. PubMed ID: 11925840
    [No Abstract]   [Full Text] [Related]  

  • 11. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
    Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
    Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term drug treatments of schizophrenia].
    des Lauriers A; Allilaire JF
    Rev Prat; 1980 Jan; 30(1):39-46. PubMed ID: 6103572
    [No Abstract]   [Full Text] [Related]  

  • 13. Early hospital experience with fluphenazine decanoate.
    Small JG; Kellams J
    Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to withdraw from multi-high-dose drug therapy for schizophrenia].
    Ishigooka J
    Seishin Shinkeigaku Zasshi; 2006; 108(6):597-8. PubMed ID: 16910536
    [No Abstract]   [Full Text] [Related]  

  • 17. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Continuity in the neuroleptic treatment in patients with schizophrenia. Current data].
    Tignol J; Plagnol C; Auriacombe M; Cazenave M; O'Brien CP
    Ann Med Psychol (Paris); 1990 Mar; 148(3):290-3. PubMed ID: 1978624
    [No Abstract]   [Full Text] [Related]  

  • 19. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacology: much the same.
    Grgas M; Ehret MJ
    Conn Med; 2009 May; 73(5):281-4. PubMed ID: 19441763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.